HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

A trial of adenosine for the termination of supraventricular tachycardia in infancy: a case report.

Abstract
A 40-day-old male infant was admitted due to cough, anorexia and pale face. Rapid heart beat was found accidentally by auscultation. Electrocardiograms revealed supraventricular tachycardia (SVT) with a heart rate up to 250 beats per minute, and an absence of P waves. Intravenous bolus injection of 1 mg adenosine terminated the tachycardia, followed by transient complete atrioventricular block, then latent Wolff-Parkinson-White (WPW) syndrome with retrograde P waves. Adenosine may be a new trial for the termination of SVT, and also is a safe drug even in the presence of WPW syndrome.
AuthorsJ R Wu, T Y Huang, W S Lo, S N Wu
JournalGaoxiong yi xue ke xue za zhi = The Kaohsiung journal of medical sciences (Gaoxiong Yi Xue Ke Xue Za Zhi) Vol. 8 Issue 6 Pg. 338-41 (Jun 1992) ISSN: 0257-5655 [Print] China (Republic : 1949- )
PMID1404538 (Publication Type: Case Reports, Clinical Trial, Journal Article)
Chemical References
  • Adenosine
Topics
  • Adenosine (therapeutic use)
  • Humans
  • Infant
  • Male
  • Tachycardia, Supraventricular (drug therapy)
  • Wolff-Parkinson-White Syndrome (drug therapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: